Diamyd Medical’s rights issue oversubscribed
Diamyd Medical announced today that the Company's new issue has been subscribed to 129 %. Subscription from the underwriting consortium will therefore not be used. In total, in addition to compensation to underwriters and financial advisor, 25 375 993 units were subscribed for, of which 18 271 908 with preferential rights and 7 104 085 without preferential rights. Due to the oversubscription, the Board has decided to utilize the available over-allotment of MSEK 20 in its entirety through a separate direct issue of 5 714 286 units. In total, Diamyd Medical will receive proceeds of SEK 88.8